Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.646
-0.014 (-2.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Cellyan Biotechnology Market Cap
Cellyan Biotechnology has a market cap or net worth of $15.18 million as of April 28, 2026. Its market cap has increased by 25.52% in one year.
Market Cap
15.18M
Enterprise Value
14.97M
1-Year Change
25.52%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since the IPO on January 15, 2025, Cellyan Biotechnology's market cap has decreased from $44.00M to $15.18M, a decrease of -65.50%. That is a compound annual growth rate of -56.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 15.18M | 67.41% |
| Dec 31, 2025 | 9.07M | -79.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 774.09B |
| Johnson & Johnson | 545.62B |
| AbbVie | 348.16B |
| UnitedHealth Group | 335.21B |
| Theriva Biologics | 15.75M |
| IN8bio | 15.66M |
| Regentis Biomaterials | 15.59M |
| SeaStar Medical Holding | 15.58M |